/daily ·05 AUG 2026 ·WEDNESDAY ·3 MIN READ ·6 STORIES

Senolytics, centenarian microbes, and a protein that poisons aging brains

Senolytic and senomorphic research continues to branch; a bacterium found only in centenarian guts reduced intestinal aging markers in mice; and a scaffolding protein may be the proximal trigger for age-related protein clumping in neurons.

01 / The Day

WEDNESDAY 05 AUG 2026, ranked

Low-dose navitoclax combined with quercetin shows senolytic effects in mice with improved safety profile

A mouse study tested low-dose navitoclax combined with quercetin as a senolytic regimen. The combination cleared senescent cells at navitoclax doses too low to cause the platelet depletion that has limited its clinical development, while quercetin enhanced selectivity for senescent cells. Tissue aging markers were measured at 4 and 8 weeks post-treatment.

Why it mattersNavitoclax's platelet toxicity has been the primary barrier to clinical senolytic use. A combination approach reducing the required dose addresses that barrier without abandoning the compound's potency.

01 fightaging.org↗

Clostridium scindens, enriched in centenarian guts, reduces intestinal aging markers in aged mice

A study found that Clostridium scindens — over-represented in centenarian gut microbiomes relative to younger controls — reduced intestinal permeability and inflammatory markers in aged mice after colonisation. The bacterium produces secondary bile acids that modulate intestinal immune tone.

Why it mattersCentenarian microbiome studies are typically correlational. This one added a mechanistic step — colonisation in a model organism with measurable tissue outcomes — which is more informative than sequencing data alone.

02 fightaging.org↗

Higher biological age acceleration independently predicts 30-day post-surgical mortality — clinical study

A clinical study found PhenoAge acceleration — a blood-based biological age score derived from clinical labs — independently predicted 30-day post-surgical mortality after controlling for surgical complexity, comorbidities, and chronological age. Patients in the highest PhenoAge acceleration quartile had 3.4x the mortality rate of the lowest quartile.

Why it mattersA pre-surgical biological age score that outperforms standard risk stratification would be immediately actionable in clinical settings. This study's scale and control set makes it harder to dismiss than earlier correlational work.

03 fightaging.org↗

Blood proteomics panel detects metabolic liver disease 16 years before clinical onset — Nature Aging

A Nature Aging study validated a 12-protein blood panel that detected metabolic liver disease (MASLD) a median of 16 years before clinical diagnosis in a prospective cohort. The panel uses proteins measurable from a standard blood draw and performed consistently across sex and BMI subgroups.

Why it mattersSixteen years of lead time on a condition currently diagnosed late — often after cirrhosis — is clinically significant if the panel holds up in a larger validation cohort.

04 nature.com↗

EPS8 scaffolding protein accumulates in aging neurons and triggers toxic protein clumping

Researchers identified EPS8, a scaffolding protein that regulates actin dynamics, as accumulating in neurons with age. In aged brain tissue, elevated EPS8 disrupted normal protein degradation pathways, leading to aggregation of tau and other proteins associated with neurodegeneration. Knockdown of EPS8 in aged mice reduced aggregate burden.

Why it mattersIdentifying a specific scaffolding protein — rather than a broad pathway — as a proximal driver of age-related protein aggregation gives drug developers a more tractable target.

05 sciencedaily.com↗

Senomorphic therapies — suppressing senescent cell secretions without clearing cells — reviewed for current state

A review article assessed senomorphic therapies, which suppress the pro-inflammatory secretome (SASP) of senescent cells without clearing them. Most candidates remain in preclinical development. Head-to-head mouse studies show SASP suppression without cell clearance produces more modest effects than senolytics.

Why it mattersThe distinction between senolytics (clearing senescent cells) and senomorphics (quieting them) matters for safety profiles — senescent cells perform wound-healing roles and wholesale clearance carries theoretical risks. The review maps where the field currently stands on that tradeoff.

06 fightaging.org↗

Be subscriber #013 the weekly ten, every friday by email · no spam · unsubscribe anytime

Past days

The Daily Archive

/WED 05 AUGSenolytics, centenarian microbes, and a protein that poisons aging brains /MON 03 AUGProtein, lifespan ceilings, and uneven clocks /FRI 31 JULBlood proteins predict liver disease 16 years early /WED 29 JULWednesday, 29 July — Clocks, guts, heat /MON 27 JULFDA Splits the Peptide Vote, Salk Finds Zombie Cells' Weakness, and GBD Says Healthy Years Aren't Keeping Pace /FRI 24 JULThe Drug That Lost Its Heart /WED 22 JULBlood, bone, and the morbidity gap /FRI 17 JULFriday in Longevity: Clocks, Fat, and Immune Decay /WED 15 JULSenescent terrain /MON 13 JULLecanemab under the skin /FRI 10 JULLongevity | Jul 10 2026: Gut, Senescence, Epigenetics /WED 08 JULDrugs remapped to aging hallmarks, ovarian aging reversed, and a 50% molecular gap /MON 06 JULCentenarian chemistry, sleeping circuits, and reprogrammed eyes /FRI 03 JULOvaries, progenitors, and oxygen /WED 01 JULTelomere signals, proteomic clocks, and faster biological aging /MON 29 JUNMonday, June 29 — Longevity /FRI 26 JUNWhen you sleep matters; what your cells do with miscopied RNA also matters /TUE 23 JUNGenes, Clocks, and GLP-1s /MON 22 JUNMonday: Senescent cells, climbing clocks, and late-life gene therapy /FRI 19 JUNLongevity — June 19, 2026 /WED 17 JUNClocks, Loops, and One Very Productive Bacteria